Trial intelligence / Profile preview

Liraglutide plus laparoscopic adjustable gastric banding for diabetes control

2011-001538-41Phase 3Terminated

Sponsor: University of Birmingham
Start: May 2011
Modality: Peptides
Countries: 1

Overview

Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and obesity comparing Gastric band + placebo with Gastric band + liraglutide (2 arms). Primary endpoint: Diabetes resolution. Started May 2011; status: terminated.

Drugs

liraglutide

Conditions

type 2 diabetes mellitus (T2DM)obesity

Beyond the preview

Go deeper on 2011-001538-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-001538-41.